| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |